Usefulness and limits of CA-125 in diagnosis of endometriosis without associated ovarian endometriomas

Condition tags

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

Cited by (8)

• <span data-contrast="auto">Evaluating the Prognostic Potential of CA-125 and miRNA Levels in Endometriosis: A Narrative Review <span data-ccp-props="{"> 2024
• Increasing trends in Deep Infiltrating Endometriosis (DIE) with Bilateral Endometrioma from Adolescence till Menopause: Case Series 2019
• Elevación de los marcadores de estrés oxidativo en pacientes con endometriosis. 2019
• Serum carcinogenic antigen (CA)-125 and CA 19-9 combining pain score in the diagnosis of pelvic endometriosis in infertile women 2016
• A Comparison of Treatment Modalities in 69 Patients with Endometriosis and/or Endometrioma and Review of the Literature 2015
• CA-125 concentration in serum and peritoneal fluid in patients with endometriosis – preliminary results 2012
• Avaliação do CA-125 e do CD-23 solúvel em pacientes com endometriose pélvica 2011
• Abordagem da dor pélvica crônica em mulheres 2006

Source provenance

openalex

last seen: 2026-06-10T17:14:06.276822+00:00